Cite
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
MLA
Michael A. Morgan, et al. “Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.” Cancers, vol. 12, July 2020, p. 1889. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....66c4c932399b8406d91a9b82b408842f&authtype=sso&custid=ns315887.
APA
Michael A. Morgan, Dorota Kaniowska, Martin Bentler, Hildegard Büning, & Ulrich T. Hacker. (2020). Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives. Cancers, 12, 1889.
Chicago
Michael A. Morgan, Dorota Kaniowska, Martin Bentler, Hildegard Büning, and Ulrich T. Hacker. 2020. “Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.” Cancers 12 (July): 1889. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....66c4c932399b8406d91a9b82b408842f&authtype=sso&custid=ns315887.